Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > EBIT

Amag Pharmaceuticals EBIT Chart (AMAG)

Amag Pharmaceuticals annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Amag Pharmaceuticals EBIT for the quarter ending June 06, 2020 was $-13m a -35.93% increase of 5m year over year
  • Amag Pharmaceuticals EBIT for the last 12 months ending June 06, 2020 was $-92m a -16.54% increase of 15m year over year
  • Amag Pharmaceuticals Annual EBIT for 2019 was $-132m a 50.06% decrease of -66m from 2018
  • Amag Pharmaceuticals Annual EBIT for 2018 was $-66m a 148.05% decrease of -98m from 2017
  • Amag Pharmaceuticals Annual EBIT for 2017 was $32m a -299.28% decrease of -95m from 2016
Other Income Statement Metrics:
  • Amag Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $0m a -35,031.33% decrease of -29m year over year
  • Amag Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $-22m a -143.49% increase of 32m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG EBIT Data

06/2020$-13m
03/2020$-17m
12/2019$-45m
09/2019$-18m
06/2019$-34m
03/2019$-35m
12/2018$-21m
09/2018$-7m
06/2018$-8m
03/2018$-30m

Annual AMAG EBIT Data

2019$-132m
2018$-66m
2017$32m
2016$127m
2015$131m
2014$8m
2013$-7m
2012$-13m
2011$-72m
2010$-81m